Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
34 Leser
Artikel bewerten:
(0)

P-Logi 2019 and 5th Cold Chain Pharma Forum to Present Intelligent Upgrading of Pharmaceutical Logistics Equipment, Rapid Development of Cold Chain Transport Market

SHANGHAI, Dec. 11, 2018 /PRNewswire/ -- P-Logi 2019 and 5th Cold Chain Pharma Forum, hosted by CCCMHPIE, UBM EMEA and UBM Sinoexpo, will take place at Shanghai New International Expo Centre (SNIEC) together with CPhI China from June 18-20, 2019. They will join hands with the concurrent Pharma Automation & Information Zone, a special block of P-MEC China, to unlock the new development opportunities of the "intelligent pharmaceuticals" era for intelligent logistics and storage, and bring an international, high-quality annual event for the pharmaceutical logistics industry.

Meeting the high efficiency, timeliness, quality safety, and other requirements for pharmaceutical transportation through automatic and information technology and equipment is a common challenge for pharmaceutical enterprises, making upgrading logistics equipment capacity a priority. Pharmaceutical logistics enterprises also need to help pharmaceutical enterprises achieve regulated and automatic operations of the logistics transportation process with the help of key technologies and equipment.

P-MEC Layout

Eight Scopes to Cover the Whole Industry Chain of Pharmaceutical Logistics

P-Logi 2019 and the concurrent pharmaceutical industry exhibitions will use all 17 exhibition halls of SNIEC, with a total 200,000m2 exhibition area. It will receive over 3,200 exhibitors and over 50,000 Chinese and overseas professional visitors, to jointly participate in the annual event of the pharmaceutical industry.

The 2019 exhibition will cover 8 scopes of exhibits including logistics equipment and materials, intelligent logistics, storage equipment and materials, cold chain technology and materials, logistics transportation services, pharmaceutical third-party logistics, Internet of Things, and dangerous goods logistics. It will showcase intelligently upgraded products to pharmaceutical and biopharmaceutical enterprises. Well-known pharmaceutical cold chain solution providers and cold chain logistics material enterprises including World Courier, Dupont, Dometic, and Emball'iso will all appear in the exhibition.

Intelligent Logistics

Cold Chain

Equipment & Materials

Storage

Logistics Services

Third Party Logistics

Dangerous Goods

Internet of Things

Gathering Well-known Pharmaceutical Enterprises of the Industry, Building an Event of Pharmaceutical Logistics

P-Logi 2019 and the concurrent CPhI China and bioLIVE China will link with each other, run through the whole pharmaceutical industry chain, gather Chinese and overseas well-known pharmaceutical enterprises and biopharmaceutical enterprises, and set up a platform for providers of logistics storage and transportation equipment as well as providers of cold chain services to directly communicate with people in charge of logistics and supply chain of pharmaceutical enterprises.

Over 2,000 API and intermediate enterprises, over 150 biopharmaceutical enterprises, and thousands of pharmaceutical manufacturers from over 120 countries and regions will gather at SNIEC, including AstraZeneca, Eli Lilly, GSK, Sanofi, Bayer, Sinopharm, Jinghua Pharmaceutical, Tonglian Group, Apeloa Kangyu, Kaifeng Pharmaceutical, Roche, Yangtze River Pharmaceutical, Shanghai Pharmaceuticals Holding, CSPC, Livzon Pharmaceutical Group, Fosun Pharma, Gan & Lee Pharmaceuticals, Peking University Sinobioway, Shenzhen Mellow Hope, Changchun GenSci, Dongbao Enterprise, 3SBio, Zhejiang Peptites, Chengdu Shengnuo, and Xiamen Amoytop.

P-Logi 2018

Cold Chain Pharma Forum to Gather Experts

Concurrently with the exhibition, the host will invite Chinese industry experts to discuss pharmaceutical cold chain regulations, market trends, policy interpretation, and comparison of overseas logistics regulations, etc., in association with China Pharmacy Cold Chain Alliance and Beijing Royal Sino Cargo Co., Ltd.

Cold Chain Pharma Forum will attract the participation of over 100 professionals in the biopharmaceutical and pharmaceutical cold chain transport industries, to promote implementation of standardization in pharmaceutical cold chain and transport industry, and boost pharmaceutical cold chain industry to upgrade and be geared to international standards.

Cold Chain Pharma Forum

P-Logi 2019

5th Cold Chain Pharma Forum
June 18-20, 2019 | SNIEC Shanghai, China
http://www.p-logi.com/en-us/Home

Photo - https://mma.prnewswire.com/media/794612/UBM_layout.jpg
Photo - https://mma.prnewswire.com/media/794614/UBM_p_logi.jpg
Photo - https://mma.prnewswire.com/media/794613/UBM_pharma_forum.jpg

© 2018 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.